Literature DB >> 25070098

Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

Marija Guzvinec1, Radosław Izdebski2, Iva Butic3, Marko Jelic3, Maja Abram4, Iva Koscak5, Anna Baraniak2, Waleria Hryniewicz2, Marek Gniadkowski2, Arjana Tambic Andrasevic3.   

Abstract

A population analysis of 103 multidrug-resistant Pseudomonas aeruginosa isolates from Croatian hospitals was performed. Twelve sequence types (STs) were identified, with a predominance of international clones ST235 (serotype O11 [41%]), ST111 (serotype O12 [15%]), and ST132 (serotype O6 [11%]). Overexpression of the natural AmpC cephalosporinase was common (42%), but only a few ST235 or ST111 isolates produced VIM-1 or VIM-2 metallo-β-lactamases or PER-1 or GES-7 extended-spectrum β-lactamases.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25070098      PMCID： PMC4187922          DOI： 10.1128/AAC.03116-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  39 in total

1.  Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.

Authors:  Esther Viedma; Carlos Juan; Joshi Acosta; Laura Zamorano; Joaquín R Otero; Francisca Sanz; Fernando Chaves; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

2.  Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France.

Authors:  Frédéric Janvier; Katy Jeannot; Sophie Tessé; Marjorie Robert-Nicoud; Hervé Delacour; Christophe Rapp; Audrey Mérens
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic.

Authors:  Alexandr Nemec; Lenka Krizova; Martina Maixnerova; Martin Musilek
Journal:  Res Microbiol       Date:  2010-02-13       Impact factor: 3.992

5.  Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa.

Authors:  E Edalucci; R Spinelli; L Dolzani; M Letizia Riccio; V Dubois; E Angelo Tonin; G M Rossolini; C Lagatolla
Journal:  Clin Microbiol Infect       Date:  2007-11-06       Impact factor: 8.067

6.  Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary.

Authors:  Balázs Libisch; Joseph Watine; Boglárka Balogh; Mária Gacs; Mónika Muzslay; Gitta Szabó; Miklós Füzi
Journal:  Res Microbiol       Date:  2008-01-11       Impact factor: 3.992

Review 7.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.

Authors:  Carlos Juan; Alejandro Beceiro; Olivia Gutiérrez; Sebastián Albertí; Margalida Garau; José L Pérez; Germán Bou; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

9.  Surveillance for antimicrobial resistance in Croatia.

Authors:  Arjana Tambic Andrasevic; Tera Tambic; Smilja Kalenic; Vera Jankovic
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

10.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640
View more
  13 in total

1.  VIM-2-Producing Pseudomonas spp. in Uruguay: Sequence Types, Pulsotypes, and Class 1 Integrons Including New Variable Regions Featuring blaVIM-2 and blaGES-7.

Authors:  Romina Papa Ezdra; Inés Bado; Nicolás Cordeiro; Claudia Gutierrez; Patricia Hitateguy; Verónica Seija; Rafael Vignoli
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Authors:  Ester Del Barrio-Tofiño; Carla López-Causapé; Gabriel Cabot; Alba Rivera; Natividad Benito; Concepción Segura; María Milagro Montero; Luisa Sorlí; Fe Tubau; Silvia Gómez-Zorrilla; Nuria Tormo; Raquel Durá-Navarro; Esther Viedma; Elena Resino-Foz; Marta Fernández-Martínez; Claudia González-Rico; Izaskun Alejo-Cancho; Jose Antonio Martínez; Cristina Labayru-Echverria; Carlos Dueñas; Ignacio Ayestarán; Laura Zamorano; Luis Martinez-Martinez; Juan Pablo Horcajada; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Persistence and epidemic propagation of a Pseudomonas aeruginosa sequence type 235 clone harboring an IS26 composite transposon carrying the blaIMP-1 integron in Hiroshima, Japan, 2005 to 2012.

Authors:  Wataru Shimizu; Shizuo Kayama; Shuntaro Kouda; Yoshitoshi Ogura; Kanao Kobayashi; Norifumi Shigemoto; Norimitsu Shimada; Raita Yano; Junzo Hisatsune; Fuminori Kato; Tetsuya Hayashi; Taijiro Sueda; Hiroki Ohge; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

4.  Prevalence and Molecular Typing of Colistin-Resistant Pseudomonas aeruginosa (CRPA) Among β-Lactamase-Producing Isolates: A Study Based on High-Resolution Melting Curve Analysis Method.

Authors:  Hamed Tahmasebi; Sanaz Dehbashi; Mohammad Reza Arabestani
Journal:  Infect Drug Resist       Date:  2020-08-21       Impact factor: 4.003

Review 5.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

6.  Coordination of las regulated virulence factors with Multidrug-Resistant and extensively drug-resistant in superbug strains of P. aeruginosa.

Authors:  Sanaz Dehbashi; Mohammad Reza Pourmand; Mohammad Yousef Alikhani; Sara Soleimani Asl; Mohammad Reza Arabestani
Journal:  Mol Biol Rep       Date:  2020-05-30       Impact factor: 2.742

7.  Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia.

Authors:  Mohamed H Al-Agamy; Katy Jeannot; Taghrid S El-Mahdy; Hassan A Samaha; Atef M Shibl; Patrick Plésiat; Patrice Courvalin
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-08-11       Impact factor: 2.471

Review 8.  Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.

Authors:  Emily M Eichenberger; Joshua T Thaden
Journal:  Antibiotics (Basel)       Date:  2019-04-06

9.  Whole Genome Sequencing of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Resistant Pseudomonas aeruginosa Isolated from a Blood Stream Infection Reveals VEB and Chromosomal Metallo-Beta Lactamases as Genetic Determinants: A Case Report.

Authors:  Aisha M Alamri; Somayah Alfifi; Yasser Aljehani; Amani Alnimr
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

10.  Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India.

Authors:  Mahjabeen Khan; Fiona Stapleton; Stephen Summers; Scott A Rice; Mark D P Willcox
Journal:  Antibiotics (Basel)       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.